TuHURA Biosciences Inc has a consensus price target of $11.5 based on the ratings of 2 analysts. The high is $12 issued by HC Wainwright & Co. on May 16, 2025. The low is $11 issued by Rodman & Renshaw on December 19, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 16, 2025, April 3, 2025, and March 3, 2025, respectively. With an average price target of $12.33 between HC Wainwright & Co., there's an implied 307.04% upside for TuHURA Biosciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/16/2025 | Buy Now | 296.04% | HC Wainwright & Co. | Robert Burns44% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
04/03/2025 | Buy Now | 296.04% | HC Wainwright & Co. | Robert Burns44% | $13 → $12 | Maintains | Buy | Get Alert |
03/03/2025 | Buy Now | 329.04% | HC Wainwright & Co. | Robert Burns44% | → $13 | Initiates | → Buy | Get Alert |
12/19/2024 | Buy Now | 263.04% | Rodman & Renshaw | Tony Butler42% | → $11 | Initiates | → Buy | Get Alert |
The latest price target for TuHURA Biosciences (NASDAQ:HURA) was reported by HC Wainwright & Co. on May 16, 2025. The analyst firm set a price target for $12.00 expecting HURA to rise to within 12 months (a possible 296.04% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for TuHURA Biosciences (NASDAQ:HURA) was provided by HC Wainwright & Co., and TuHURA Biosciences reiterated their buy rating.
There is no last upgrade for TuHURA Biosciences
There is no last downgrade for TuHURA Biosciences.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TuHURA Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TuHURA Biosciences was filed on May 16, 2025 so you should expect the next rating to be made available sometime around May 16, 2026.
While ratings are subjective and will change, the latest TuHURA Biosciences (HURA) rating was a reiterated with a price target of $12.00 to $12.00. The current price TuHURA Biosciences (HURA) is trading at is $3.03, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.